Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 20, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/20/17 - "Composition and Method for Treatment of Depression and Psychosis in Humans" in Patent Application Approval Process (USPTO 20170312275)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Javitt, Daniel C., filed on July 16, 2017, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Glytech LLC. "Diagnosis of schi
11/20/17 - "Dual-Chamber Pack for Pharmaceutical Compositions" in Patent Application Approval Process (USPTO 20170312177)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BHARGAVA, Rahul; MITTAL, Bhupesh Kumar, filed on May 2, 2016, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a
11/20/17 - "Low Dose Pharmaceutical Composition" in Patent Application Approval Process (USPTO 20170312254)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors MALHOTRA, Geena; PURANDARE, Shrinivas Madhukar, filed on July 14, 2017, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assi
11/20/17 - "Mission: Cure" Launched to Harness Innovative Financing and Impact Investing to Cure Disease; Pioneers New Approach by Attacking Pancreatic Disease
By a News Reporter-Staff News Editor at Clinical Trials Week The new nonprofit Mission: Cure will convene the world's leading pancreatic experts at the American Pancreatic Association meeting in San Diego on November 10th to devise a 10- year plan to cure chronic pancreatitis, a painful and costly pancreatic disease, using an innovative financing
11/20/17 - "Pharmaceutical Composition and Use Thereof" in Patent Application Approval Process (USPTO 20170312234)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor Lin, Jung-Yaw, filed on May 2, 2016, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to National Taiwan Normal University.
11/20/17 - "Pyrazolo[1,5-A]pyridine Compounds and Use Thereof" in Patent Application Approval Process (USPTO 20170313697)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors Lu, Xiaoyun; Tang, Jian; Ding, Ke; Zhang, Tianyu; Zhang, Xiantao; Tu, Zhengchao; Wu, Tian; Wan, Junting; Cao, Yuanyuan; He, Shengjiang, filed on August 13, 2015, was made available online on November 9, 2017, according to news reporting originating
11/20/17 - 'It never really leaves you.' Opioids haunt users' recovery
Addiction to powerful painkillers has ensnared millions of Americans, and created the worst drug epidemic in U.S. history. Now many share a daily struggle for recovery, a battle fraught with ironies, tragedies and sometimes shaky success. Survival means rejecting cravings for a high, often with the help of anti-addiction medicine similar to pills t
11/20/17 - Acadia Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on November 7, 2017. The SEC file number is 0001564590-17-022271.. A U.S. Securities and Exchange Commission f
11/20/17 - Acadia Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on November 7, 2017. The SEC file number is 0001415889-17-001754.. A U.S. Securities and Exchange Commission f
11/20/17 - Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner
Acasti Pharma Inc., a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, today announced that the company recently entered into a non-binding term sheet with a leading China- based pharmaceutical company.
11/20/17 - Acceleron Announces Appointment of Dr. Karen Smith to its Board of Directors and Departure of Terrance McGuire
CAMBRIDGE, Mass.- Acceleron Pharma Inc. today announced the appointment of the experienced biopharmaceutical executive, Karen Smith, M.D., Ph.D., to its board of directors and the departure of Terrance McGuire, effective November 15, 2017. Dr. Smith currently serves as Executive Vice President, Global Head R&D, and Chief Medical Officer of Jazz Pha
11/20/17 - Acceleron Pharma Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on November 7, 2017. The SEC file number is 0001280600-17-000055.. A U.S. Securities and Exchange Commission filing
11/20/17 - Acceleron Pharma Inc. Files SEC Form 8-K, Current Report: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on November 7, 2017. The SEC file number is 0001280600-17-000054.. A U.S. Securities and Exchange Commission filing
11/20/17 - AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain
REDWOOD CITY, Calif.- AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, reported the publication of a manuscript analyzing sufentanil sublingual tablet 30 mcg for postoperative pain in the peer-reviewed journal
11/20/17 - Adamas Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on November 2, 2017. The SEC file number is 0001628280-17-010669.. A U.S. Securities and Exchange Commission f
11/20/17 - Adamas Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Nov. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on November 2, 2017. The SEC file number is 0001628280-17-010673.. A U.S. Securities and Exchange Commission f
11/20/17 - Adocia Reports Topline Results of BioChaperone Glucagon Phase 1 Study
ADOCIA a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, today announced top-line results of a Phase 1 study of BioChaperone Glucagon, its aqueous formulation of human glucagon. Stanislav Glezer, Adocia s Chief Medical Officer. We are currently selecting an easy-to-u
11/20/17 - Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration
Advanced Proteome Therapeutics Corporation a biotechnology company focused on developing superior targeted protein therapeutics, is expanding the collaboration with the National Research Council of Canada and receiving support from its Industrial Research Assistance Program to conduct key steps in development of APC's novel technology.
11/20/17 - Advaxis, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Nov. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Advaxis, Inc. was posted on November 2, 2017. The SEC file number is 0001493152-17-012357.. A U.S. Securities and Exchange Commission filing is a for
11/20/17 - Advaxis, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Nov. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Advaxis, Inc. was posted on November 6, 2017. The SEC file number is 0001493152-17-012496.. A U.S. Securities and Exchange Commission filing is a for
11/20/17 - Agile Therapeutics Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agile Therapeutics Inc. was posted on November 6, 2017. The SEC file number is 0001104659-17-066342.. A U.S. Securities and Exchange Commission filin
11/20/17 - Agile Therapeutics Inc. Files SEC Form 8-K, Current Report: (Nov. 3, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agile Therapeutics Inc. was posted on November 3, 2017. The SEC file number is 0001104659-17-065846.. A U.S. Securities and Exchange Commission filin
11/20/17 - Agile Therapeutics Inc. Files SEC Form 8-K, Current Report: (Nov. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agile Therapeutics Inc. was posted on November 6, 2017. The SEC file number is 0001104659-17-066334.. A U.S. Securities and Exchange Commission filin
11/20/17 - Agios Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Nov. 3, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agios Pharmaceuticals Inc. was posted on November 3, 2017. The SEC file number is 0001209191-17-059135.. A U.S. Securities and Exchange Commission fi
11/20/17 - Aimmune Therapeutics to Host Investor Symposium on Peanut Allergy Treatment with Leading Expert Allergists on Friday, December 1
Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it will host an Investor Symposium in New York City on December 1, 2017. Ellen R. Sher, MD, is an allergist and immunologist of Allergy Partners of New Jersey, P.C., Section Chief of Allergy and Immunology at Monmo
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415